Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

specialty lab

Investors Pump $107 Million Into Unilab’s Stock Offering

HERE’S ENCOURAGING NEWS for owners of independent regional laboratories: investors on Wall Street continue to like the laboratory business…a lot! Latest confirmation of this fact came on June 6, when Unilab Corporation of Tarzana, California funded its initial public offering (I…

Read More



Unilab Files Registration For IPO of $115 Million

CEO SUMMARY: During the 1990s, Unilab used the twin strategies of lab acquisitions and aggressive sales and marketing to fuel rapid growth in specimen volumes and net revenues. However, California’s ultra-competitive managed care market and severe financial problems during the latter ha…

Read More



Public Labs Enjoy Boom Times As Revenues & Profits Climb

TAKEN COLLECTIVELY, second quarter earnings reports by public lab and pathology companies send a strong message: the lab industry is in the midst of a revenue and profit boom. It’s been more than a decade since every public lab and pathology company reported strong growth in both revenues and oper…

Read More



Luminex Test Technology Entering Clinical Usage

CEO SUMMARY: Multi-analyte diagnostic testing is moving closer to widespread clinical usage. During the past 12 months, several of the nation’s largest laboratory companies have begun to use Luminex Corporation’s LabMAP™ system to generate patient test results. At the same time, the…

Read More



“April 30, 2001 Intelligence: Late Breaking Lab News”

It seems some companies serving the laboratory industry have learned the importance of having a better understanding of the inner workings of Washington, DC. Both Cerner Corporation and Specialty Laboratories, Inc. will add Nancy-Ann DeParle to their respective Board…

Read More



Identifying Future Lab Winners From Losers

TODAY I WOULD LIKE TO DO SOME CRYSTAL BALL-GAZING as a way to make a point about strategic business planning for laboratories. …

Read More



Specialty Labs and Dynacare Have Balance Sheet Differences

SINCE LAST FALL’S SUCCESSFUL IPOs (initial public offering) raised $92 million for Specialty Laboratories, Inc. and $50 million for Dynacare, Inc., the financial fortunes of the two lab companies have begun moving in different directions. Lab administrators and pa…

Read More



Lab Industry Easing Back to Financial Stability

IT MAY NOT BE JUBILATION, BUT THERE’S CERTAINLY LESS DESPERATION among laboratories around the United States. In travels around the country, both commercial laboratories and hospital laboratories tell THE DARK REPORT that the 2000 was unusually free of crises. It was also a more productive financia…

Read More



DIANON Systems, IMPATH, Specialty Labs, Dynacare, Quest, LabCorp

DIANON & IMPATH REPORT 2000 EARNINGS TWO OF THE NATIONAL anatomic pathology companies reported fourth quarter earnings. Both DIANON Systems, Inc. and IMPATH, Inc. posted big gains in revenues and operating profits for 2000. At DIANON Systems, revenues r…

Read More



“Local” Anatomic Path Has Two Major Players

CEO SUMMARY: After a lot of money and much effort, the fledgling crop of companies wanting to consolidate and manage pathology group practices has narrowed into just two market leaders: AmeriPath and Pathology Service Associates. These two companies could not be more different in their go…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;